首页 > 最新文献

International Journal of Artificial Organs最新文献

英文 中文
Impact of preoperative arterial stiffness index on graft patency following peripheral arterial bypass surgery. 术前动脉僵硬指数对外周动脉搭桥术后移植物通畅的影响。
IF 1.3 4区 医学 Q4 ENGINEERING, BIOMEDICAL Pub Date : 2026-02-01 Epub Date: 2026-02-24 DOI: 10.1177/03913988261422333
Mustafa Selcuk Atasoy, Hakan Guven, Ahmet Yuksel, Demir Cetintas, Gencehan Kumtepe, Yusuf Velioglu

Introduction: We aimed to investigate the impact of preoperative Arterial Stiffness Index (ASI) values on primary graft patency following peripheral arterial bypass surgery.

Methods: This retrospective cohort study included 92 patients who underwent femoro-popliteal bypass surgery between January 2019 and November 2024. Preoperative ASI values were measured using the Vasolab 5000 device. Patients were divided into two groups based on an ASI cut-off value of 10.0. Primary graft patency rates, Kaplan-Meier survival analysis, and multivariate Cox regression were performed to assess the relationship between ASI and graft outcomes.

Results: Patients with ASI >10.0 exhibited significantly lower 12-month primary graft patency rates compared to those with ASI ⩽10.0 (61.9% vs 88.0%, p = 0.008). Multivariate Cox regression analysis identified high ASI as an independent predictor of graft failure (HR: 2.15; 95% CI: 1.15-4.03; p = 0.016), along with diabetes mellitus and the use of synthetic graft material.

Conclusion: Preoperative ASI values are independently associated with primary graft patency after peripheral arterial bypass surgery. Arterial stiffness assessment may serve as a useful non-invasive tool for risk stratification in vascular surgery candidates.

前言:我们的目的是研究术前动脉硬度指数(ASI)值对周围动脉搭桥手术后移植物初级通畅的影响。方法:本回顾性队列研究纳入了2019年1月至2024年11月期间接受股腘动脉搭桥手术的92例患者。术前ASI值使用Vasolab 5000设备测量。根据ASI分值10.0将患者分为两组。通过一期移植物通畅率、Kaplan-Meier生存分析和多变量Cox回归来评估ASI与移植物结局之间的关系。结果:与ASI≥10.0的患者相比,ASI≥10.0的患者12个月一期移植物通畅率显著降低(61.9% vs 88.0%, p = 0.008)。多因素Cox回归分析发现,高ASI是移植物失败的独立预测因子(HR: 2.15; 95% CI: 1.15-4.03; p = 0.016),以及糖尿病和使用合成移植物材料。结论:术前ASI值与外周动脉搭桥术后移植物一期通畅独立相关。动脉硬度评估可作为血管外科候选人危险分层的有用的非侵入性工具。
{"title":"Impact of preoperative arterial stiffness index on graft patency following peripheral arterial bypass surgery.","authors":"Mustafa Selcuk Atasoy, Hakan Guven, Ahmet Yuksel, Demir Cetintas, Gencehan Kumtepe, Yusuf Velioglu","doi":"10.1177/03913988261422333","DOIUrl":"10.1177/03913988261422333","url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to investigate the impact of preoperative Arterial Stiffness Index (ASI) values on primary graft patency following peripheral arterial bypass surgery.</p><p><strong>Methods: </strong>This retrospective cohort study included 92 patients who underwent femoro-popliteal bypass surgery between January 2019 and November 2024. Preoperative ASI values were measured using the Vasolab 5000 device. Patients were divided into two groups based on an ASI cut-off value of 10.0. Primary graft patency rates, Kaplan-Meier survival analysis, and multivariate Cox regression were performed to assess the relationship between ASI and graft outcomes.</p><p><strong>Results: </strong>Patients with ASI >10.0 exhibited significantly lower 12-month primary graft patency rates compared to those with ASI ⩽10.0 (61.9% vs 88.0%, <i>p</i> = 0.008). Multivariate Cox regression analysis identified high ASI as an independent predictor of graft failure (HR: 2.15; 95% CI: 1.15-4.03; <i>p</i> = 0.016), along with diabetes mellitus and the use of synthetic graft material.</p><p><strong>Conclusion: </strong>Preoperative ASI values are independently associated with primary graft patency after peripheral arterial bypass surgery. Arterial stiffness assessment may serve as a useful non-invasive tool for risk stratification in vascular surgery candidates.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"100-107"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the effect of sarcopenia and frailty on quality of life in older hemodialysis patients. 老年血液透析患者肌少症和虚弱对生活质量影响的评价。
IF 1.3 4区 医学 Q4 ENGINEERING, BIOMEDICAL Pub Date : 2026-02-01 Epub Date: 2026-01-21 DOI: 10.1177/03913988251412192
Fatma Büşra Çakır Kunt, Fatih Ergül, Çağdaş Kunt, Fatih Saçkan, İbrahim Güney, Muhammet Cemal Kızılarslanoğlu

Background: This study aimed to evaluate the impact of sarcopenia and frailty on the quality of life of older hemodialysis patients.

Methods: Seventy hemodialysis patients aged ⩾60 years were assessed. Daily living activities (Katz Index), depression (Yesavage Scale), frailty (Fried's Criteria), and sarcopenia (EWGSOP2) were evaluated. Quality of life was measured using the KDQOL-36 questionnaire.

Results: The median age was 67 years, and 50% were female. Nineteen patients (27.1%) were partially dependent, 71.4% were pre-frail, and 15.7% were frail. Probable sarcopenia was detected in 77.1%, and sarcopenia in 8.6% of patients. Sarcopenia was associated with older age, higher dependency, depression, lower income, and frailty (p < 0.05). It was also related to the KDQOL-36 physical component (p = 0.031), while frailty correlated with the symptom component (p = 0.047).

Conclusion: Frailty and sarcopenia are common in older hemodialysis patients and adversely affect their quality of life.

背景:本研究旨在评估骨骼肌减少症和虚弱对老年血液透析患者生活质量的影响。方法:评估70名年龄大于或等于60岁的血液透析患者。对日常生活活动(Katz指数)、抑郁(Yesavage量表)、虚弱(Fried标准)和肌肉减少症(EWGSOP2)进行评估。生活质量采用KDQOL-36问卷进行测量。结果:中位年龄67岁,女性占50%。部分依赖19例(27.1%),体弱前期71.4%,体弱期15.7%。77.1%的患者检出可能的肌肉减少症,8.6%的患者检出肌肉减少症。骨骼肌减少症与年龄较大、依赖性较高、抑郁、收入较低和虚弱相关(p p = 0.031),而虚弱与症状相关(p = 0.047)。结论:老年血透患者体弱多病和肌肉减少症普遍存在,并对其生活质量产生不良影响。
{"title":"Evaluation of the effect of sarcopenia and frailty on quality of life in older hemodialysis patients.","authors":"Fatma Büşra Çakır Kunt, Fatih Ergül, Çağdaş Kunt, Fatih Saçkan, İbrahim Güney, Muhammet Cemal Kızılarslanoğlu","doi":"10.1177/03913988251412192","DOIUrl":"10.1177/03913988251412192","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the impact of sarcopenia and frailty on the quality of life of older hemodialysis patients.</p><p><strong>Methods: </strong>Seventy hemodialysis patients aged ⩾60 years were assessed. Daily living activities (Katz Index), depression (Yesavage Scale), frailty (Fried's Criteria), and sarcopenia (EWGSOP2) were evaluated. Quality of life was measured using the KDQOL-36 questionnaire.</p><p><strong>Results: </strong>The median age was 67 years, and 50% were female. Nineteen patients (27.1%) were partially dependent, 71.4% were pre-frail, and 15.7% were frail. Probable sarcopenia was detected in 77.1%, and sarcopenia in 8.6% of patients. Sarcopenia was associated with older age, higher dependency, depression, lower income, and frailty (<i>p</i> < 0.05). It was also related to the KDQOL-36 physical component (<i>p</i> = 0.031), while frailty correlated with the symptom component (<i>p</i> = 0.047).</p><p><strong>Conclusion: </strong>Frailty and sarcopenia are common in older hemodialysis patients and adversely affect their quality of life.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"126-132"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146009871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Albumin dialysis modeling predicts the impact of polysulfone dialyzers and flow rate on cholic acid and indoxyl sulfate removal. 白蛋白透析模型预测了聚砜透析器和流速对胆酸和吲哚酚硫酸盐去除的影响。
IF 1.3 4区 医学 Q4 ENGINEERING, BIOMEDICAL Pub Date : 2026-02-01 Epub Date: 2026-02-08 DOI: 10.1177/03913988251415094
Alexander Novokhodko, Nanye Du, Shaohang Hao, Ziyuan Wang, Martin Sadilek, Zhiquan Shu, Suhail Ahmad, Dayong Gao

Cholic acid (CA) and indoxyl sulfate (IS) are toxins associated with biliary and renal disease. Protein binding prevents removal by traditional dialysis. Dissolving binding molecules such as albumin in dialysate enables detoxification. We created a benchtop albumin dialysis test platform. We used it to validate a mathematical model of CA/IS removal. Toxin-containing blood analog solution was dialyzed using two dialyzers at five flow rates against albumin dialysate. One condition was used to estimate toxin binding affinity to albumin and the free toxin transmembrane transfer coefficient (KfreeA). Other conditions validated modeling results and revealed the impact of dialysate flow rate and dialyzer properties on detoxification (measured by mass spectrometry). We accurately predicted CA/IS removal. The normalized root mean squared error never exceeds 11.5% of the starting amount. Increasing dialysate side flow rate up to 150 mL/min improved toxin removal. Further increases produced no benefit. KfreeA was independent of flow rate. Our data fits a result from the newly developed AMOR system, in which total bile acids declined with treatment. This model and benchtop setup aim to predict clinical CA/IS clearance and optimize device design for clinical trials. This will mean fewer unsuccessful trials and enable testing of new dialysate formulations.

胆酸(CA)和硫酸吲哚酚(IS)是与胆道和肾脏疾病相关的毒素。蛋白质结合阻止了传统透析的去除。溶解透析液中的结合分子,如白蛋白,可以解毒。我们创建了一个台式白蛋白透析测试平台。我们用它来验证CA/IS去除的数学模型。含毒素血液模拟溶液用两个透析器以五种流速对白蛋白透析液进行透析。用一个条件估计毒素与白蛋白的结合亲和力和游离毒素跨膜传递系数(KfreeA)。其他条件验证了模型结果,并揭示了透析液流速和透析器性能对解毒的影响(通过质谱测定)。我们准确地预测了CA/IS的去除。归一化均方根误差从不超过起始量的11.5%。增加透析液侧流量高达150毫升/分钟改善毒素去除。进一步的增加没有带来任何好处。KfreeA与流量无关。我们的数据符合新开发的AMOR系统的结果,其中总胆汁酸随着治疗而下降。该模型和台式设置旨在预测临床CA/IS清除并优化临床试验的设备设计。这将意味着更少不成功的试验,并使新的透析液配方得以测试。
{"title":"Albumin dialysis modeling predicts the impact of polysulfone dialyzers and flow rate on cholic acid and indoxyl sulfate removal.","authors":"Alexander Novokhodko, Nanye Du, Shaohang Hao, Ziyuan Wang, Martin Sadilek, Zhiquan Shu, Suhail Ahmad, Dayong Gao","doi":"10.1177/03913988251415094","DOIUrl":"10.1177/03913988251415094","url":null,"abstract":"<p><p>Cholic acid (CA) and indoxyl sulfate (IS) are toxins associated with biliary and renal disease. Protein binding prevents removal by traditional dialysis. Dissolving binding molecules such as albumin in dialysate enables detoxification. We created a benchtop albumin dialysis test platform. We used it to validate a mathematical model of CA/IS removal. Toxin-containing blood analog solution was dialyzed using two dialyzers at five flow rates against albumin dialysate. One condition was used to estimate toxin binding affinity to albumin and the free toxin transmembrane transfer coefficient (K<sub>free</sub>A). Other conditions validated modeling results and revealed the impact of dialysate flow rate and dialyzer properties on detoxification (measured by mass spectrometry). We accurately predicted CA/IS removal. The normalized root mean squared error never exceeds 11.5% of the starting amount. Increasing dialysate side flow rate up to 150 mL/min improved toxin removal. Further increases produced no benefit. K<sub>free</sub>A was independent of flow rate. Our data fits a result from the newly developed AMOR system, in which total bile acids declined with treatment. This model and benchtop setup aim to predict clinical CA/IS clearance and optimize device design for clinical trials. This will mean fewer unsuccessful trials and enable testing of new dialysate formulations.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"115-125"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of the CA330 cytokine adsorption cartridge for coupled plasma filtration adsorption therapy in severe acute pancreatitis-induced cytokine storm: A case report. CA330细胞因子吸附盒在重症急性胰腺炎细胞因子风暴耦合血浆过滤吸附治疗中的应用1例
IF 1.3 4区 医学 Q4 ENGINEERING, BIOMEDICAL Pub Date : 2026-02-01 Epub Date: 2026-02-24 DOI: 10.1177/03913988261422649
Xiankun Sun, Fang Wang, Li Lin, Xue Tang, Zhiwen Chen, Ling Zhang

This case describes an 82-year-old male patient presenting with persistent upper abdominal colic, diagnosed as severe acute pancreatitis. The patient then suffered a cytokine storm, as well as renal dysfunction. Therefore, the patient underwent two sessions of coupled plasma filtration adsorption (CPFA) therapy utilising the CA330 cytokine adsorption cartridge as the adsorbent. The first CPFA session lasted 8 h, followed by a 4-h interval (during which continuous veno-venous haemodialysis therapy was provided), and the second 8-h CPFA session started. Due to family requests and comprehensive consideration by the medical team, the second CPFA session was extended to 20 h. Ultimately, the patient was weaned off blood purification therapy (43 h after its initiation). The study demonstrated a significant reduction in cytokine levels as the course of treatment increased. However, beyond a specific threshold, cytokine adsorption may reach saturation. The medicinal applications of CPFA (particularly CA330) deserve more investigation.

这个病例描述了一个82岁的男性病人表现为持续性上腹部绞痛,诊断为严重急性胰腺炎。然后,患者遭受细胞因子风暴,以及肾功能障碍。因此,患者接受了两次耦合血浆过滤吸附(CPFA)治疗,使用CA330细胞因子吸附盒作为吸附剂。第一次CPFA持续8小时,随后是4小时的间隔(在此期间提供连续的静脉-静脉血液透析治疗),第二次CPFA持续8小时。由于家属的要求和医疗小组的全面考虑,第二次方案协商会议延长至20小时。最终,患者停止了血液净化治疗(开始治疗43小时后)。该研究表明,随着治疗过程的增加,细胞因子水平显著降低。然而,超过特定阈值,细胞因子的吸附可能达到饱和。CPFA(特别是CA330)的医学应用值得进一步研究。
{"title":"Application of the CA330 cytokine adsorption cartridge for coupled plasma filtration adsorption therapy in severe acute pancreatitis-induced cytokine storm: A case report.","authors":"Xiankun Sun, Fang Wang, Li Lin, Xue Tang, Zhiwen Chen, Ling Zhang","doi":"10.1177/03913988261422649","DOIUrl":"10.1177/03913988261422649","url":null,"abstract":"<p><p>This case describes an 82-year-old male patient presenting with persistent upper abdominal colic, diagnosed as severe acute pancreatitis. The patient then suffered a cytokine storm, as well as renal dysfunction. Therefore, the patient underwent two sessions of coupled plasma filtration adsorption (CPFA) therapy utilising the CA330 cytokine adsorption cartridge as the adsorbent. The first CPFA session lasted 8 h, followed by a 4-h interval (during which continuous veno-venous haemodialysis therapy was provided), and the second 8-h CPFA session started. Due to family requests and comprehensive consideration by the medical team, the second CPFA session was extended to 20 h. Ultimately, the patient was weaned off blood purification therapy (43 h after its initiation). The study demonstrated a significant reduction in cytokine levels as the course of treatment increased. However, beyond a specific threshold, cytokine adsorption may reach saturation. The medicinal applications of CPFA (particularly CA330) deserve more investigation.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"108-114"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biodegradable patch based on chitosan-collagen with glycerol plasticizer as scaffold for tympanic membrane perforation. 壳聚糖-胶原-甘油增塑剂的可生物降解鼓膜穿孔贴片支架。
IF 1.3 4区 医学 Q4 ENGINEERING, BIOMEDICAL Pub Date : 2026-02-01 Epub Date: 2026-02-24 DOI: 10.1177/03913988251412204
Prihartini Widiyanti, Arkan Fahrian Putra, Djony Izak Rudyardjo

Perforation on tympanic membrane could decrease the hearing ability. In some cases, myringoplasty should be performed. Myringoplasty requires material as patch to cover tympanic membrane's hole. This study is aimed to create innovation based on chitosan-collagen with glycerol plasticizers as scaffold patch for tympanic membrane perforation. The sample preparation method included mixing various concentrations of chitosan-collagen with the ratio of 1:0; 9:1; 8:2; 7:3 and 0.5 ml of glycerol for each sample variation. The characterization included FTIR test, morphological test, sound transmission class test, tensile strength test, degradation test, swelling test, and antibacterial test. The functional group test showed that in the sample variations 9:1; 8:2; 7:3 there was an absorption at the wave number 2347 cm-1 which showed deformation of the NH group. Morphological analysis showed that as the collagen concentration increased, the microstructure exhibited more pronounced fine wrinkles. The sound transmission class test showed all sample variations did not reduce the sound so the scaffold patch transmitted sound properly. Tensile strength test showed the sample with the variation of 8:2 had the greatest strength value (8.02 MPa) but still below the value of tympanic membrane tensile strength ±20 MPa. The degradation test showed the samples were able to survive during the tympanic membrane healing process for approximately one until 2 months. The optimization of plasticizer amount need to be adjusted in order to increase tensile strength. The presence of free hydrophilic groups (group COOH, NH2, and -OH) cause the sample to have hydrophilic properties so that it is easily degraded and undergoes swelling. In antibacterial assay, the inhibition zone was not formed because chitosan could not diffuse through the agar.

鼓膜穿孔可使听力下降。在某些情况下,应进行鼓膜成形术。鼓膜成形术需要材料作为补片覆盖鼓膜孔。本研究旨在利用壳聚糖-胶原蛋白和甘油增塑剂作为鼓膜穿孔支架补片进行创新。样品制备方法为:将不同浓度的壳聚糖-胶原蛋白以1:0的比例混合;9:1;的宣告;7:3和0.5 ml甘油对每个样品的变化。表征包括FTIR测试、形态学测试、传声等级测试、拉伸强度测试、降解测试、溶胀测试和抗菌测试。官能团检验表明,样品变异率为9:1;的宣告;7:3在波数2347 cm-1处有吸收,表明NH基团发生了变形。形态学分析表明,随着胶原浓度的增加,微结构呈现出更明显的细皱纹。声音传输等级测试表明,所有的样品变化都没有降低声音,因此支架贴片可以正确地传输声音。拉伸强度试验结果表明,当试样的强度变化为8:2时,试样的强度值最大(8.02 MPa),但仍低于鼓膜拉伸强度±20 MPa。降解试验表明,在鼓膜愈合过程中,样品能够存活约1 ~ 2个月。为了提高拉伸强度,需要调整增塑剂用量的优化。自由亲水性基团(COOH、NH2和-OH基团)的存在使样品具有亲水性,使其易于降解和膨胀。在抑菌试验中,由于壳聚糖不能通过琼脂扩散,没有形成抑菌带。
{"title":"Biodegradable patch based on chitosan-collagen with glycerol plasticizer as scaffold for tympanic membrane perforation.","authors":"Prihartini Widiyanti, Arkan Fahrian Putra, Djony Izak Rudyardjo","doi":"10.1177/03913988251412204","DOIUrl":"10.1177/03913988251412204","url":null,"abstract":"<p><p>Perforation on tympanic membrane could decrease the hearing ability. In some cases, myringoplasty should be performed. Myringoplasty requires material as patch to cover tympanic membrane's hole. This study is aimed to create innovation based on chitosan-collagen with glycerol plasticizers as scaffold patch for tympanic membrane perforation. The sample preparation method included mixing various concentrations of chitosan-collagen with the ratio of 1:0; 9:1; 8:2; 7:3 and 0.5 ml of glycerol for each sample variation. The characterization included FTIR test, morphological test, sound transmission class test, tensile strength test, degradation test, swelling test, and antibacterial test. The functional group test showed that in the sample variations 9:1; 8:2; 7:3 there was an absorption at the wave number 2347 cm<sup>-1</sup> which showed deformation of the NH group. Morphological analysis showed that as the collagen concentration increased, the microstructure exhibited more pronounced fine wrinkles. The sound transmission class test showed all sample variations did not reduce the sound so the scaffold patch transmitted sound properly. Tensile strength test showed the sample with the variation of 8:2 had the greatest strength value (8.02 MPa) but still below the value of tympanic membrane tensile strength ±20 MPa. The degradation test showed the samples were able to survive during the tympanic membrane healing process for approximately one until 2 months. The optimization of plasticizer amount need to be adjusted in order to increase tensile strength. The presence of free hydrophilic groups (group COOH, NH2, and -OH) cause the sample to have hydrophilic properties so that it is easily degraded and undergoes swelling. In antibacterial assay, the inhibition zone was not formed because chitosan could not diffuse through the agar.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"133-140"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional status of arteriovenous fistula and quality of life in hemodialysis patients. 血液透析患者动静脉瘘功能状况与生活质量的关系。
IF 1.3 4区 医学 Q4 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 Epub Date: 2025-12-14 DOI: 10.1177/03913988251398849
Elif Bulbul, Elçin Sebahat Kasapoğlu, Meryem Yildiz Ayvaz

Aim: This study aimed to assess the relationship between arteriovenous fistula (AVF) functional status and quality of life and to identify influencing factors.

Method: Data for this cross-sectional study were collected from 221 chronic hemodialysis patients between May and September 2024.

Results: AVF functional status was significantly lower in male patients who had undergone four or more AVF operations, had an AVF at the elbow site, or had two to three temporary catheter insertions. There was a moderate negative correlation between the SF-12 Physical Composite and age and a positive correlation between Kt/V. There was a moderate negative correlation between the SF-12 Physical Composite and AVF-AS. The regression analysis revealed that the blood pump speed, Kt/V, and the SF-12 Physical Composite significantly affected the AVF-AS scores, explaining 21.5% of the total variance.

Conclusion: In our study, we founded that a well-functioning AVF provided adequate dialysis, improving the patients' physical quality of life.

目的:探讨动静脉瘘(AVF)功能状态与生活质量的关系,并探讨影响因素。方法:收集2024年5月至9月期间221例慢性血液透析患者的横断面研究数据。结果:接受过4次或以上AVF手术、在肘部有AVF或有2 - 3次临时导管插入的男性患者的AVF功能状态明显较低。SF-12物理综合指数与年龄呈中等负相关,与Kt/V呈正相关。SF-12物理综合指数与AVF-AS呈中度负相关。回归分析显示,血泵速度、Kt/V和SF-12 Physical Composite显著影响AVF-AS评分,解释总方差的21.5%。结论:在我们的研究中,我们发现一个功能良好的AVF可以提供足够的透析,改善患者的身体生活质量。
{"title":"Functional status of arteriovenous fistula and quality of life in hemodialysis patients.","authors":"Elif Bulbul, Elçin Sebahat Kasapoğlu, Meryem Yildiz Ayvaz","doi":"10.1177/03913988251398849","DOIUrl":"10.1177/03913988251398849","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to assess the relationship between arteriovenous fistula (AVF) functional status and quality of life and to identify influencing factors.</p><p><strong>Method: </strong>Data for this cross-sectional study were collected from 221 chronic hemodialysis patients between May and September 2024.</p><p><strong>Results: </strong>AVF functional status was significantly lower in male patients who had undergone four or more AVF operations, had an AVF at the elbow site, or had two to three temporary catheter insertions. There was a moderate negative correlation between the SF-12 Physical Composite and age and a positive correlation between <i>Kt</i>/<i>V</i>. There was a moderate negative correlation between the SF-12 Physical Composite and AVF-AS. The regression analysis revealed that the blood pump speed, <i>Kt</i>/<i>V</i>, and the SF-12 Physical Composite significantly affected the AVF-AS scores, explaining 21.5% of the total variance.</p><p><strong>Conclusion: </strong>In our study, we founded that a well-functioning AVF provided adequate dialysis, improving the patients' physical quality of life.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"11-16"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of vortex characteristics and energy dissipation mechanisms in the high-shear-stress flow fields of blood-handling devices. 血液处理装置高剪切应力流场涡旋特性及能量耗散机制研究。
IF 1.3 4区 医学 Q4 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 Epub Date: 2025-12-17 DOI: 10.1177/03913988251401780
Zheqin Yu, Jin Liu, Jianping Tan, Zhiyong Xiao, Yuanying Du

Blood-handling devices are commonly used for blood transportation or regulation, but their specialized flow channel geometries tend to create high-shear-stress flow regimes, which may induce excessive cellular damage risks and energy dissipation. To address this, this study combines computational fluid dynamics and particle image velocimetry experimental methods to establish nozzle reference models with multiple orifice diameter configurations. Based on entropy generation theory and Ω vortex identification methods, the underlying energy dissipation mechanisms and vortex dynamics under distinct high-shear-stress conditions are analyzed. The results indicate that shear flow intensity is highly correlated with energy dissipation due to entropy production. Attenuating turbulence in the flow field simultaneously suppresses shear stress damage and energy loss, while lowering shear flow intensity promotes the decomposition of vortices downstream, broadening their spatial distribution. High flow velocity alone does not directly induce shear stress or entropy-related energy dissipation; rather, an excessively steep velocity gradient is the primary factor affecting flow field safety and efficiency. A 94% rise in velocity gradient results in average increases of 97.6% in shear stress and 99.6% in energy entropy production. During flow regime transition or under pronounced velocity gradients, shear-dominated vortices readily form and generate vortex-like energy dissipation during evolution, which is a key factor exacerbating energy loss in high-shear-stress flow fields. This study elucidates the energy dissipation mechanisms and vortex dynamics in high-shear-stress flow fields of blood-handling devices, providing theoretical and technical support for optimizing flow fields and performance in relevant devices.

血液处理装置通常用于血液运输或调节,但其特殊的流动通道几何形状往往会产生高剪切应力流动状态,这可能会导致过度的细胞损伤风险和能量耗散。为了解决这一问题,本研究结合计算流体力学和粒子图像测速实验方法,建立了多孔径配置的喷嘴参考模型。基于熵生理论和Ω涡旋识别方法,分析了不同高剪切应力条件下的能量耗散机制和涡旋动力学。结果表明,剪切流动强度与熵产生的能量耗散密切相关。流场湍流度的减弱同时抑制了剪切应力损伤和能量损失,而剪切流强度的降低促进了下游涡的分解,扩大了其空间分布。单独的高流速不会直接引起剪切应力或熵相关的能量耗散;过大的速度梯度是影响流场安全性和效率的主要因素。速度梯度增大94%,剪应力平均增大97.6%,能量熵产平均增大99.6%。在流型转换或明显的速度梯度下,剪切主导型涡在演化过程中容易形成并产生涡状能量耗散,这是加剧高剪切应力场能量损失的关键因素。本研究阐明了血液处理装置高剪切应力流场的能量耗散机制和涡旋动力学,为优化相关装置的流场和性能提供理论和技术支持。
{"title":"Investigation of vortex characteristics and energy dissipation mechanisms in the high-shear-stress flow fields of blood-handling devices.","authors":"Zheqin Yu, Jin Liu, Jianping Tan, Zhiyong Xiao, Yuanying Du","doi":"10.1177/03913988251401780","DOIUrl":"10.1177/03913988251401780","url":null,"abstract":"<p><p>Blood-handling devices are commonly used for blood transportation or regulation, but their specialized flow channel geometries tend to create high-shear-stress flow regimes, which may induce excessive cellular damage risks and energy dissipation. To address this, this study combines computational fluid dynamics and particle image velocimetry experimental methods to establish nozzle reference models with multiple orifice diameter configurations. Based on entropy generation theory and Ω vortex identification methods, the underlying energy dissipation mechanisms and vortex dynamics under distinct high-shear-stress conditions are analyzed. The results indicate that shear flow intensity is highly correlated with energy dissipation due to entropy production. Attenuating turbulence in the flow field simultaneously suppresses shear stress damage and energy loss, while lowering shear flow intensity promotes the decomposition of vortices downstream, broadening their spatial distribution. High flow velocity alone does not directly induce shear stress or entropy-related energy dissipation; rather, an excessively steep velocity gradient is the primary factor affecting flow field safety and efficiency. A 94% rise in velocity gradient results in average increases of 97.6% in shear stress and 99.6% in energy entropy production. During flow regime transition or under pronounced velocity gradients, shear-dominated vortices readily form and generate vortex-like energy dissipation during evolution, which is a key factor exacerbating energy loss in high-shear-stress flow fields. This study elucidates the energy dissipation mechanisms and vortex dynamics in high-shear-stress flow fields of blood-handling devices, providing theoretical and technical support for optimizing flow fields and performance in relevant devices.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"62-82"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145767964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dialysis symptoms, fluid compliance, and related factors in hemodialysis patients. 血液透析患者的透析症状、液体依从性及相关因素
IF 1.3 4区 医学 Q4 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 Epub Date: 2026-01-05 DOI: 10.1177/03913988251403838
Elif Bulbul, Selda Çelik, Aysun Ünal, Üstün Yilmaz, Tuğba Çepken

Aim: Patients with ESRD who receive dialysis experience a wide range of unpleasant symptoms that have a negative effect on patient prognosis. The aim of this study was to evaluate the relationship between dialysis symptoms, adherence to interdialytic weight gain, fluid control, and associated factors in hemodialysis patients.

Methods: This study was conducted in a descriptive and cross-sectional design. Demographic and clinical characteristics form, mean of interdialytic weight gain last 12 hemodialysis sessions, Fluid Control in Hemodialysis Patients Scale, and Dialysis Symptom Index (DSI) were used to collect data.

Results: Patients with chronic illnesses and unemployment patients experienced higher DSI scores. The literate participants had a significantly higher DSI and lower adequacy of fluid intake. The regression analysis results showed that employment, chronic diseases, dialysis adequacy, and compliance with fluid intake explained 20.3% of the variance and that the model was a significant predictor of the DSI.

Conclusion: Dialysis symptoms were seen prevalently among the patients, and factors such as employment status, chronic disease, dialysis adequacy, and fluid intake compliance affected the DSI. It is important to monitor the fluid volume status and hemodialysis symptoms of hemodialysis patients regularly.

目的:接受透析治疗的ESRD患者会经历各种不愉快的症状,这些症状对患者预后有负面影响。本研究的目的是评估血液透析患者的透析症状、坚持透析间期体重增加、体液控制和相关因素之间的关系。方法:本研究采用描述性和横断面设计。采用人口统计学和临床特征表、最近12次血液透析期间平均体重增加、血液透析患者体液控制量表和透析症状指数(DSI)收集数据。结果:慢性疾病患者和失业患者的DSI得分较高。识字的参与者有显著较高的DSI和较低的液体摄入充分性。回归分析结果显示,就业、慢性病、透析充分性和液体摄入依从性解释了20.3%的方差,该模型是DSI的显著预测因子。结论:透析症状在患者中普遍存在,其影响因素包括就业状况、慢性疾病、透析充分性、液体摄入依从性等。定期监测血透患者的液量状况和血透症状是很重要的。
{"title":"Dialysis symptoms, fluid compliance, and related factors in hemodialysis patients.","authors":"Elif Bulbul, Selda Çelik, Aysun Ünal, Üstün Yilmaz, Tuğba Çepken","doi":"10.1177/03913988251403838","DOIUrl":"10.1177/03913988251403838","url":null,"abstract":"<p><strong>Aim: </strong>Patients with ESRD who receive dialysis experience a wide range of unpleasant symptoms that have a negative effect on patient prognosis. The aim of this study was to evaluate the relationship between dialysis symptoms, adherence to interdialytic weight gain, fluid control, and associated factors in hemodialysis patients.</p><p><strong>Methods: </strong>This study was conducted in a descriptive and cross-sectional design. Demographic and clinical characteristics form, mean of interdialytic weight gain last 12 hemodialysis sessions, Fluid Control in Hemodialysis Patients Scale, and Dialysis Symptom Index (DSI) were used to collect data.</p><p><strong>Results: </strong>Patients with chronic illnesses and unemployment patients experienced higher DSI scores. The literate participants had a significantly higher DSI and lower adequacy of fluid intake. The regression analysis results showed that employment, chronic diseases, dialysis adequacy, and compliance with fluid intake explained 20.3% of the variance and that the model was a significant predictor of the DSI.</p><p><strong>Conclusion: </strong>Dialysis symptoms were seen prevalently among the patients, and factors such as employment status, chronic disease, dialysis adequacy, and fluid intake compliance affected the DSI. It is important to monitor the fluid volume status and hemodialysis symptoms of hemodialysis patients regularly.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"3-10"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145900370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracorporeal membrane oxygenation in pediatric septic shock: A single-center experience in Chile. 儿童感染性休克的体外膜氧合:智利的单中心经验。
IF 1.3 4区 医学 Q4 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 Epub Date: 2026-01-16 DOI: 10.1177/03913988251409039
Loreto Godoy, Mauricio Yunge, Jorge Rufs, Alejandra Gatica, Carlos Muñoz, Cristian Valverde

Background: Refractory septic shock (RSS) in children carries high mortality despite advances in critical care. Extracorporeal membrane oxygenation (ECMO) is a rescue therapy when conventional management fails. Evidence from Latin America remains limited, with no detailed reports from Chile.

Methods: We conducted a retrospective single-center study (2009-2024) in a Chilean Pediatric ICU. Patients aged 1 month to 17 years with septic shock unresponsive to maximal conventional therapy were included. We analyzed demographics, illness severity, ECMO modality, complications, and outcomes. Primary endpoint was survival to hospital discharge.

Results: Nine patients received ECMO (median age = 6.3 years). All had RSS, frequently associated with severe ARDS. Configurations included venoarterial (VA; n = 4), venovenous (VV; n = 4), and venoarteriovenous (VAV; n = 1), all via peripheral cannulation. Pre-ECMO median vasoactive-inotropic score was 117, and 78% required renal replacement therapy during ECMO. Overall survival was 55% (5/9). Survivors had longer ECMO runs (median 11 days vs 3 days) and ICU stays (median 63 days vs 5 days). Hemorrhage was the most frequent complication (intracranial n = 3; gastrointestinal n = 1). One survivor developed hemiparesis; no cognitive impairment was observed at 1-year follow-up.

Conclusions: ECMO can be an effective rescue therapy for pediatric RSS, even without central cannulation capability. Distinguishing cardiogenic from vasoplegic phenotypes and identifying severe ARDS guided configuration selection (VA vs VV). These findings highlight the feasibility of peripheral ECMO in carefully selected patients within resource-limited settings, achieving survival comparable to international reports.

背景:难治性脓毒性休克(RSS)在儿童中具有很高的死亡率,尽管在重症监护方面取得了进展。体外膜氧合(ECMO)是常规治疗失败时的一种抢救治疗方法。来自拉丁美洲的证据仍然有限,没有来自智利的详细报告。方法:我们在智利儿科ICU进行了一项回顾性单中心研究(2009-2024)。年龄1个月至17岁的感染性休克患者对最大常规治疗无反应。我们分析了人口统计学、疾病严重程度、ECMO模式、并发症和结果。主要终点是生存至出院。结果:9例患者接受ECMO(中位年龄6.3岁)。所有患者均有RSS,常伴有严重的ARDS。构型包括静脉动脉(VA, n = 4)、静脉静脉(VV, n = 4)和静脉动静脉(VAV, n = 1),均通过外周插管。ECMO前血管活性-肌力评分中位数为117,其中78%在ECMO期间需要肾脏替代治疗。总生存率为55%(5/9)。幸存者的ECMO运行时间较长(中位11天对3天),ICU住院时间较长(中位63天对5天)。出血是最常见的并发症(颅内n = 3,胃肠道n = 1)。一名幸存者患上偏瘫;随访1年未见认知障碍。结论:即使没有中心插管能力,ECMO也可以作为儿童RSS的有效抢救治疗。区分心源性和血管截瘫表型并识别严重ARDS引导构型选择(VA vs VV)。这些发现强调了在资源有限的情况下,在精心选择的患者中进行外周ECMO的可行性,实现了与国际报道相当的生存率。
{"title":"Extracorporeal membrane oxygenation in pediatric septic shock: A single-center experience in Chile.","authors":"Loreto Godoy, Mauricio Yunge, Jorge Rufs, Alejandra Gatica, Carlos Muñoz, Cristian Valverde","doi":"10.1177/03913988251409039","DOIUrl":"10.1177/03913988251409039","url":null,"abstract":"<p><strong>Background: </strong>Refractory septic shock (RSS) in children carries high mortality despite advances in critical care. Extracorporeal membrane oxygenation (ECMO) is a rescue therapy when conventional management fails. Evidence from Latin America remains limited, with no detailed reports from Chile.</p><p><strong>Methods: </strong>We conducted a retrospective single-center study (2009-2024) in a Chilean Pediatric ICU. Patients aged 1 month to 17 years with septic shock unresponsive to maximal conventional therapy were included. We analyzed demographics, illness severity, ECMO modality, complications, and outcomes. Primary endpoint was survival to hospital discharge.</p><p><strong>Results: </strong>Nine patients received ECMO (median age = 6.3 years). All had RSS, frequently associated with severe ARDS. Configurations included venoarterial (VA; <i>n</i> = 4), venovenous (VV; <i>n</i> = 4), and venoarteriovenous (VAV; <i>n</i> = 1), all via peripheral cannulation. Pre-ECMO median vasoactive-inotropic score was 117, and 78% required renal replacement therapy during ECMO. Overall survival was 55% (5/9). Survivors had longer ECMO runs (median 11 days vs 3 days) and ICU stays (median 63 days vs 5 days). Hemorrhage was the most frequent complication (intracranial <i>n</i> = 3; gastrointestinal <i>n</i> = 1). One survivor developed hemiparesis; no cognitive impairment was observed at 1-year follow-up.</p><p><strong>Conclusions: </strong>ECMO can be an effective rescue therapy for pediatric RSS, even without central cannulation capability. Distinguishing cardiogenic from vasoplegic phenotypes and identifying severe ARDS guided configuration selection (VA vs VV). These findings highlight the feasibility of peripheral ECMO in carefully selected patients within resource-limited settings, achieving survival comparable to international reports.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"17-22"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145989227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of phenobarbital pharmacokinetics and dosing in adults receiving extracorporeal membrane oxygenation. 接受体外膜氧合的成人苯巴比妥药代动力学和剂量的表征。
IF 1.3 4区 医学 Q4 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 Epub Date: 2025-12-14 DOI: 10.1177/03913988251398850
Natasha D Lopez, Christina Jacob, Tia N Bullard

Background: Achieving adequate sedation on extracorporeal membrane oxygenation (ECMO) is challenging due to altered pharmacokinetics. Limited data exists on phenobarbital in adult ECMO patients. The aim was to characterize the volume of distribution (Vd) and dosing.

Methods: This single-center retrospective study examined adult ECMO patients who received intravenous phenobarbital and corresponding serum concentrations between January 1, 2017 and March 1, 2024. Phenobarbital levels for analysis were obtained 0.5-4 h after phenobarbital loading dose (LD) and up to 4 h prior to a maintenance dose; this time frame was adjusted to 0.5-1 h if on continuous venovenous hemofiltration (CVVH).

Results: Sixteen venovenous ECMO patients with 18 LD and 70 phenobarbital concentrations were evaluated. The median LD was 1225 mg (796.3-1437.8); 15 mg/kg (8.8-16.2) total body weight (TBW). The median total Vd was 67.7 L (46.8-80.8), 0.94 L/kg (0.72-1.22) ideal body weight (IBW), and 0.71 L/kg (0.67-0.82) TBW. Weight-based LD and concentration demonstrated a stronger correlation for TBW (r = 0.93, p < 0.001) versus IBW (r = 0.64, p = 0.003). Comparing BMI <30 and BMI ⩾30 kg/m2 patients there was a difference in total Vd (p = 0.02) and IBW-normalized Vd (p = 0.006), but no difference in TBW-normalized Vd (p = 0.31). The median maintenance dose was 2.4 mg/kg/day (1.7-2.7) TBW; CVVH patients required 11.7 mg/kg/day TBW. Phenobarbital concentration change was <3% after ECMO decannulation.

Conclusion: In adult ECMO patients, phenobarbital's Vd normalized to TBW, was consistent with critically ill non-ECMO patients. Obesity affected Vd, CVVH influenced maintenance dosing, but ECMO decannulation did not impact phenobarbital concentrations.

背景:由于药代动力学的改变,体外膜氧合(ECMO)达到足够的镇静是具有挑战性的。苯巴比妥在成人ECMO患者中的应用数据有限。目的是表征分布体积(Vd)和剂量。方法:本单中心回顾性研究对2017年1月1日至2024年3月1日接受静脉注射苯巴比妥的成人ECMO患者及其相应的血清浓度进行了调查。用于分析的苯巴比妥水平是在苯巴比妥负荷剂量(LD)后0.5-4小时和维持剂量前4小时获得的;如果进行连续静脉-静脉血液滤过(CVVH),则将该时间范围调整为0.5-1 h。结果:16例静脉-静脉ECMO患者,18例LD, 70例苯巴比妥。中位LD为1225 mg (796.3-1437.8);15 mg/kg(8.8-16.2)总体重(TBW)。总Vd中位数分别为67.7 L(46.8 ~ 80.8)、0.94 L/kg(0.72 ~ 1.22)理想体重(IBW)和0.71 L/kg (0.67 ~ 0.82) TBW。体重LD和浓度与TBW的相关性更强(r = 0.93, p r = 0.64, p = 0.003)。BMI 2组患者的总Vd (p = 0.02)和ibw归一化Vd (p = 0.006)有差异,tbw归一化Vd无差异(p = 0.31)。中位维持剂量为2.4 mg/kg/天(1.7-2.7)TBW;CVVH患者需要11.7 mg/kg/天TBW。结论:在成人ECMO患者中,苯巴比妥的Vd归一为TBW,与危重症非ECMO患者一致。肥胖影响Vd, CVVH影响维持剂量,但ECMO脱管不影响苯巴比妥浓度。
{"title":"Characterization of phenobarbital pharmacokinetics and dosing in adults receiving extracorporeal membrane oxygenation.","authors":"Natasha D Lopez, Christina Jacob, Tia N Bullard","doi":"10.1177/03913988251398850","DOIUrl":"10.1177/03913988251398850","url":null,"abstract":"<p><strong>Background: </strong>Achieving adequate sedation on extracorporeal membrane oxygenation (ECMO) is challenging due to altered pharmacokinetics. Limited data exists on phenobarbital in adult ECMO patients. The aim was to characterize the volume of distribution (Vd) and dosing.</p><p><strong>Methods: </strong>This single-center retrospective study examined adult ECMO patients who received intravenous phenobarbital and corresponding serum concentrations between January 1, 2017 and March 1, 2024. Phenobarbital levels for analysis were obtained 0.5-4 h after phenobarbital loading dose (LD) and up to 4 h prior to a maintenance dose; this time frame was adjusted to 0.5-1 h if on continuous venovenous hemofiltration (CVVH).</p><p><strong>Results: </strong>Sixteen venovenous ECMO patients with 18 LD and 70 phenobarbital concentrations were evaluated. The median LD was 1225 mg (796.3-1437.8); 15 mg/kg (8.8-16.2) total body weight (TBW). The median total Vd was 67.7 L (46.8-80.8), 0.94 L/kg (0.72-1.22) ideal body weight (IBW), and 0.71 L/kg (0.67-0.82) TBW. Weight-based LD and concentration demonstrated a stronger correlation for TBW (<i>r</i> = 0.93, <i>p</i> < 0.001) versus IBW (<i>r</i> = 0.64, <i>p</i> = 0.003). Comparing BMI <30 and BMI ⩾30 kg/m<sup>2</sup> patients there was a difference in total Vd (<i>p</i> = 0.02) and IBW-normalized Vd (<i>p</i> = 0.006), but no difference in TBW-normalized Vd (<i>p</i> = 0.31). The median maintenance dose was 2.4 mg/kg/day (1.7-2.7) TBW; CVVH patients required 11.7 mg/kg/day TBW. Phenobarbital concentration change was <3% after ECMO decannulation.</p><p><strong>Conclusion: </strong>In adult ECMO patients, phenobarbital's Vd normalized to TBW, was consistent with critically ill non-ECMO patients. Obesity affected Vd, CVVH influenced maintenance dosing, but ECMO decannulation did not impact phenobarbital concentrations.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"23-29"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Artificial Organs
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1